Derek Robert Starkey

Title: Derek Robert Starkey: Innovator in Pharmaceutical Synthesis

Introduction

Derek Robert Starkey is a notable inventor based in Avon, Indiana, who has made significant contributions to the field of pharmaceutical synthesis. With a focus on innovative processes, he has developed methods that enhance the production of important therapeutic compounds.

Latest Patents

Starkey holds a patent for a process to make GLP1 RA and intermediates therefor. This invention relates to the synthesis of a complex compound, specifically 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo [4,3-c] pyridine-5-carbonyl] indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one, or a salt thereof, along with related synthetic intermediate compounds. This patent showcases his expertise in creating effective synthesis pathways for complex molecules.

Career Highlights

Throughout his career, Starkey has worked with prominent companies in the pharmaceutical industry, including Eli Lilly and Company and Chugai Seiyaku Kabushiki Kaisha. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development efforts.

Collaborations

Starkey has collaborated with esteemed colleagues such as Ayman D Allian and Kenneth Derek Berglund. These partnerships have fostered an environment of innovation and have led to advancements in the field of pharmaceutical synthesis.

Conclusion

Derek Robert Starkey is a distinguished inventor whose work in pharmaceutical synthesis has made a lasting impact. His patent for the synthesis of GLP1 RA and his collaborations with industry leaders highlight his commitment to advancing medical science.